| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors | Aphivatanasiri, C Li, J Chan, R Jamidi, SK Tsang, JY Poon, IK Shao, Y Tong, J To, KF Chan, SK Tam, F Cheung, SY Shea, KH Tse, GM |
2020 | ||||
| 2. | Global Hypomethylation and Histone Deacetylation in Aggressive Types of Thyroid Carcinoma Detected by Immunohistochemistry and Image Analysis | Andrey Bychkov Thiyaphat Laohawetwanit Sithapong Soontornsit Chaiwat Aphivatanasiri Supinda Koonmee Somboon Keelawat |
2020 | ||||
| 3. | Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer. | Shirley K. Jamidi Jintao Hu Chaiwat Aphivatanasiri Julia Y. Tsang Ivan K. Poon Joshua J. Li Siu-Ki Chan Sai-Yin Cheung Gary M. Tse |
2020 | ||||
| 4. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. | Sawanyawisuth, K. Silsirivanit, A. Wongkham, S. Wongkham, C. |
2020 | ||||
| 5. | Papillary lesions of the breast: A systematic evaluation of cytologic parameters | Jamidi, SK Li, JJX Aphivatanasiri, C Chow, MBCY Chan, RCK Ng, JKM Tsang, JY Tse, GM |
2021 | ||||
| 6. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand. | Koonmee, S. Somintara, O. Intarawichian, P. Prachumrasee, K. |
2021 | ||||
| 7. | The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy | Monalyn Marabi Chaiwat Aphivatanasiri Shirley K. Jamidi Chao Wang Joshua J. Li Esther H. Hung Ivan K. Poon Julia Y. Tsang Gary M. Tse |
2021 | ||||
| 8. | Correlation between fibroepithelial lesions with breast core needle biopsy and surgical excision | Intarawichian, P. Kanchana, K. Kunprom, W. Somintara, O. Koonmee, S. Aphivatanasiri, C. |
2022 | ||||
| 9. | Fine needle aspiration cytology of metastatic carcinomas with papillary architecture: A systemic assessment of clinical, cytological and immunohistochemical parameters. | Li, J.J.X. Ng, J.K.M. Aphivatanasiri, C. Chan, R.C.K. Poon, I.K. Tsang, J.Y. Tse, G.M. |
2022 | ||||
| 10. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 | ||||
| 11. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 | ||||
| 12. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 13. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 | ||||
| 14. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 15. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. | Koonmee, S. Sangkhamanon, S. Intarawichian, P. Aphivatanasiri, C. Kunprom, W. Sa-Ngiamwibool, P. Balthaisong, S. Phuyao, C. Prajumwongs, P. Alaghehbandan, R. Thanee, M. |
2022 | ||||
| 16. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 | ||||
| 17. | Pathology of Cholangiocarcinoma | Koonmee, S Sa-Ngiamwibool, P Aphivatanasiri, C Kunprom, W Intarawichian, P Bamrungkit, W Sangkhamanon, S Thanee, M |
2023 | ||||
| 18. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 | ||||
| 19. | Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer | Chan, R Aphivatanasiri, C Poon, IK Tsang, JY Ni, Y Lacambra, M Li, J Lee, C Tse, GM |
2024 | ||||
| 20. | Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma. | Sintusen, P Vaeteewoottacharn, K Cha'on, U Pairojkul, C Aphivatanasiri, C Suttiprapa, S Mahalapbutr, P Silsirivanit, A Wongkham, S Luang, S |
2025 | ||||
| 21. | KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA | Thongyoo, P. Chindaprasirt, J. Aphivatanasiri, C. Intarawichian, P. Kunprom, W. |
2025 | ||||
| 22. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 | ||||
| 23. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer. | Kaewkedsri, P. Intarawichian, P. Jessadapattarakul, S. Kunprom, W. Koonmee, S. Thanee, M. Somintara, O. Wongbuddha, A. Chadbunchachai, P. Nawapun, S. Aphivatanasiri, C. |
2025 | ||||
| 24. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma | Silsirivanit, A Alvarez, MRS Grijaldo-Alvarez, SJ Gogte, R Kitkhuandee, A Piyawattanametha, N Seubwai, W Luang, S Panawan, O Mahalapbutr, P Vaeteewoottacharn, K Sawanyawisuth, K Let-Itthiporn, W Saengboonmee, C Duangthongphon, P Jingjit, K Pankongsap, A Waraasawapati, S Aphivatanasiri, C Lebrilla, CB |
2025 | Count | 17 | 20 | 7 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors | Aphivatanasiri, C. Li, J. Chan, R. Jamidi, S.K. Tsang, J.Y. Poon, I.K. Shao, Y. Tong, J. To, K.F. Chan, S.K. Tam, F. Cheung, S.Y. Shea, K.H. Tse, G.M. |
2020 |
Breast Cancer Research and Treatment 1 (184), pp. 11-21 |
||||||||
| 2. | Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer | Jamidi, S.K. Hu, J. Aphivatanasiri, C. Tsang, J.Y. Poon, I.K. Li, J. Chan, S.K. Cheung, S.Y. Tse, G.M. |
2020 |
Histopathology 6 (77), pp. 936-948 |
||||||||
| 3. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling | Sawanyawisuth, K. Silsirivanit, A. Wongkham, S. Wongkham, C. |
2020 |
Glycobiology 5 (30), pp. 312-324 |
||||||||
| 4. | Papillary lesions of the breast: A systematic evaluation of cytologic parameters | Jamidi, S.K. Li, J. Aphivatanasiri, C. Chow, M.B.C.Y. Chan, R. Ng, J.K.M. Tsang, J.Y. Tse, G.M. |
2021 |
Cancer Cytopathology 8 (129), pp. 649-661 |
||||||||
| 5. | Pathum raksa project: Addressing disparity in breast cancer care through national innovation in Thailand | Koonmee, S. Somintara, O. Intarawichian, P. Prachumrasee, K. |
2021 |
Cancer Management and Research (13), pp. 8737-8753 |
||||||||
| 6. | The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy | Marabi, M. Aphivatanasiri, C. Jamidi, S.K. Wang, C. Li, J. Hung, E.H. Poon, I.K. Tsang, J.Y. Tse, G.M. |
2021 |
Cancer Cytopathology 11 (129), pp. 852-864 |
||||||||
| 7. | Correlation between fibroepithelial lesions with breast core needle biopsy and surgical excision | Intarawichian, P. Kanchana, K. Kunprom, W. Somintara, O. Koonmee, S. Aphivatanasiri, C. |
2022 |
Asia-Pacific Journal of Science and Technology 5 (27), pp. |
||||||||
| 8. | Fine needle aspiration cytology of metastatic carcinomas with papillary architecture: A systemic assessment of clinical, cytological and immunohistochemical parameters | Li, J.J.X. Ng, J.K.M. Aphivatanasiri, C. Chan, R.C.K. Poon, I.K. Tsang, J.Y. Tse, G.M. |
2022 |
Cytopathology 3 (33), pp. 328-343 |
||||||||
| 9. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 |
HPB 11 (24), pp. 1944-1956 |
||||||||
| 10. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 |
Frontiers in Medicine (9), pp. |
||||||||
| 11. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 12. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand | Koonmee, S. Sangkhamanon, S. Intarawichian, P. Aphivatanasiri, C. Kunprom, W. Sa-Ngiamwibool, P. Balthaisong, S. Phuyao, C. Prajumwongs, P. Alaghehbandan, R. Thanee, M. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 13. | Pathology of Cholangiocarcinoma | Koonmee, S. Sa-ngiamwibool, P. Aphivatanasiri, C. Kunprom, W. Intarawichian, P. Bamrungkit, W. Sangkhamanon, S. Thanee, M. |
2023 |
Recent Results in Cancer Research (219), pp. 91-107 |
||||||||
| 14. | Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer | Chan, R. Aphivatanasiri, C. Poon, I.K. Tsang, J.Y. Ni, Y. Lacambra, M. Li, J. Lee, C. Tse, G.M. |
2024 |
Oncologist 3 (29), pp. E299-E308 |
||||||||
| 15. | KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA | Thongyoo, P. Chindaprasirt, J. Aphivatanasiri, C. Intarawichian, P. Kunprom, W. |
2025 |
Cancer Genomics and Proteomics 1 (22), pp. 112-126 |
||||||||
| 16. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer | Kaewkedsri, P. Intarawichian, P. Jessadapattarakul, S. Kunprom, W. Koonmee, S. Thanee, M. Somintara, O. Wongbuddha, A. Chadbunchachai, P. Nawapun, S. Aphivatanasiri, C. |
2025 |
Breast Cancer Targets and Therapy (17), pp. 123-143 |
||||||||
| 17. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma | Silsirivanit, A. Alvarez, M.R.S. Grijaldo-Alvarez, S.J. Gogte, R. Kitkhuandee, A. Piyawattanametha, N. Seubwai, W. Luang, S. Panawan, O. Mahalapbutr, P. Vaeteewoottacharn, K. Sawanyawisuth, K. Let-Itthiporn, W. Saengboonmee, C. Duangthongphon, P. Jingjit, K. Pankongsap, A. Waraasawapati, S. Aphivatanasiri, C. Lebrilla, C.B. |
2025 |
Journal of Proteome Research 3 (24), pp. 1402-1413 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer. | Jamidi, SK Hu, J Aphivatanasiri, C Tsang, JY Poon, IK Li, JJ Chan, SK Cheung, SY Tse, GM |
2020 |
Histopathology 6 (77), pp. 936-948 |
|
| 2. | Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors. | Aphivatanasiri, C Li, J Chan, R Jamidi, SK Tsang, JY Poon, IK Shao, Y Tong, J To, KF Chan, SK Tam, F Cheung, SY Shea, KH Tse, GM |
2020 |
Breast cancer research and treatment 1 (184), pp. 11-21 |
|
| 3. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. | Detarya, M Sawanyawisuth, K Aphivatanasiri, C Chuangchaiya, S Saranaruk, P Sukprasert, L Silsirivanit, A Araki, N Wongkham, S Wongkham, C |
2020 |
Glycobiology 5 (30), pp. 312-324 |
|
| 4. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand. | Koonmee, S Somintara, O Intarawichian, P Aphivatanasiri, C Sangkhamanon, S Laohawiriyakamol, S Panawattanakul, R Mahantassanapong, P Rattadilok, C Jeeravongpanich, P Krongyute, W Prachumrasee, K Alaghehbandan, R |
2021 |
Cancer management and research (13), pp. 8737-8753 |
|
| 5. | The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy. | Marabi, M Aphivatanasiri, C Jamidi, SK Wang, C Li, JJ Hung, EH Poon, IK Tsang, JY Tse, GM |
2021 |
Cancer cytopathology 11 (129), pp. 852-864 |
|
| 6. | Papillary lesions of the breast: A systematic evaluation of cytologic parameters. | Jamidi, SK Li, JJX Aphivatanasiri, C Chow, MBCY Chan, RCK Ng, JKM Tsang, JY Tse, GM |
2021 |
Cancer cytopathology 8 (129), pp. 649-661 |
|
| 7. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 8. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 9. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 10. | Fine needle aspiration cytology of metastatic carcinomas with papillary architecture: A systemic assessment of clinical, cytological and immunohistochemical parameters. | Li, JJX Ng, JKM Aphivatanasiri, C Chan, RCK Poon, IK Tsang, JY Tse, GM |
2022 |
Cytopathology : official journal of the British Society for Clinical Cytology 3 (33), pp. 328-343 |
|
| 11. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 12. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. | Koonmee, S Sangkhamanon, S Intarawichian, P Aphivatanasiri, C Kunprom, W Sa-Ngiamwibool, P Balthaisong, S Phuyao, C Prajumwongs, P Alaghehbandan, R Thanee, M |
2022 |
Frontiers in public health (10), pp. 792847 |
|
| 13. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1638-1648 |
|
| 14. | Pathology of Cholangiocarcinoma. | Koonmee, S Sa-Ngiamwibool, P Aphivatanasiri, C Kunprom, W Intarawichian, P Bamrungkit, W Sangkhamanon, S Thanee, M |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 91-107 |
|
| 15. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 |
Scientific reports 1 (14), pp. 13726 |
|
| 16. | Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer. | Chan, R Aphivatanasiri, C Poon, IK Tsang, JY Ni, Y Lacambra, M Li, J Lee, C Tse, GM |
2024 |
The oncologist 3 (29), pp. e299-e308 |
|
| 17. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 112-126 |
|
| 18. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer. | Kaewkedsri, P Intarawichian, P Jessadapattarakul, S Kunprom, W Koonmee, S Thanee, M Somintara, O Wongbuddha, A Chadbunchachai, P Nawapun, S Aphivatanasiri, C |
2025 |
Breast cancer (Dove Medical Press) (17), pp. 123-143 |
|
| 19. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma. | Silsirivanit, A Alvarez, MRS Grijaldo-Alvarez, SJ Gogte, R Kitkhuandee, A Piyawattanametha, N Seubwai, W Luang, S Panawan, O Mahalapbutr, P Vaeteewoottacharn, K Sawanyawisuth, K Let-Itthiporn, W Saengboonmee, C Duangthongphon, P Jingjit, K Pankongsap, A Waraasawapati, S Aphivatanasiri, C Lebrilla, CB |
2025 |
Journal of proteome research 3 (24), pp. 1402-1413 |
|
| 20. | Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma. | Sintusen, P Vaeteewoottacharn, K Cha'on, U Pairojkul, C Aphivatanasiri, C Suttiprapa, S Mahalapbutr, P Silsirivanit, A Wongkham, S Luang, S |
2025 |
Scientific reports 1 (15), pp. 436 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors | Chaiwat Aphivatanasiri Joshua Li Ronald Chan Shirley K. Jamidi Julia Y. Tsang Ivan K. Poon Yan Shao Joanna Tong Ka-Fai To Siu-Ki Chan Fiona Tam Sai-Yin Cheung Ka-Ho Shea Gary M. Tse |
2020 |
BREAST CANCER RESEARCH AND TREATMENT 1.0 (184.0), pp. 11.0-21.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 2. | Global Hypomethylation and Histone Deacetylation in Aggressive Types of Thyroid Carcinoma Detected by Immunohistochemistry and Image Analysis | Andrey Bychkov Thiyaphat Laohawetwanit Sithapong Soontornsit Chaiwat Aphivatanasiri Supinda Koonmee Somboon Keelawat |
2020 |
MODERN PATHOLOGY SUPPL 2 (33.0), pp. 568.0-569.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer | Shirley K. Jamidi Jintao Hu Chaiwat Aphivatanasiri Julia Y. Tsang Ivan K. Poon Joshua J. Li Siu-Ki Chan Sai-Yin Cheung Gary M. Tse |
2020 |
HISTOPATHOLOGY 6.0 (77.0), pp. 936.0-948.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 4. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling | Marutpong Detarya Kanlayanee Sawanyawisuth Chaiwat Aphivatanasiri Sriwipa Chuangchaiya Paksiree Saranaruk Lukkana Sukprasert Atit Silsirivanit Norie Araki Sopit Wongkham Chaisiri Wongkham |
2020 |
GLYCOBIOLOGY 5.0 (30.0), pp. 312.0-324.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 5. | Papillary lesions of the breast: A systematic evaluation of cytologic parameters | Shirley Kristina Jamidi Joshua J. X. Li Chaiwat Aphivatanasiri Maria B. C. Y. Chow Ronald C. K. Chan Joanna K. M. Ng Julia Y. Tsang Gary M. Tse |
2021 |
CANCER CYTOPATHOLOGY 8.0 (129.0), pp. 649.0-661.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 6. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand | Supinda Koonmee Ongart Somintara Piyapharom Intarawichian Chaiwat Aphivatanasiri Sakkarn Sangkhamanon Suphawat Laohawiriyakamol Rujira Panawattanakul Phanchanut Mahantassanapong Chayanoot Rattadilok Piyarat Jeeravongpanich Wilart Krongyute Krisada Prachumrasee Reza Alaghehbandan |
2021 |
CANCER MANAGEMENT AND RESEARCH (13.0), pp. 8737.0-8753.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy | Monalyn Marabi Chaiwat Aphivatanasiri Shirley K. Jamidi Chao Wang Joshua J. Li Esther H. Hung Ivan K. Poon Julia Y. Tsang Gary M. Tse |
2021 |
CANCER CYTOPATHOLOGY 11.0 (129.0), pp. 852.0-864.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|